Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Amended recombinant cells for the production and delivery of gamma interferon as an antiviral agent, adjuvant and vaccine accelerant

Amended recombinant cells for the production and delivery of gamma interferon as an antiviral agent, adjuvant and vaccine accelerant

US Patent 7338794 · Granted Mar 4, 2008

Estimated economic value: $37,273,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Relaxin analogs and methods of using the same2025
GITR antagonists and methods of using the same2024
Expression of mammalian proteins in Pseudomonas fluorescens2018
Expression of mammalian proteins in Pseudomonas fluorescens2018
Expression of mammalian proteins in Pseudomonas fluorescens2018
Expression of mammalian proteins in pseudomonas fluorescens2016
Expression of mammalian proteins in pseudomonas fluorescens2016
Expression of mammalian proteins in pseudomonas fluorescens2016
Expression of mammalian proteins in Pseudomonas fluorescens2016
Expression of mammalian proteins in Pseudomonas fluorescens2016
Expression of mammalian proteins in Pseudomonas fluorescens2016
High copy number self-replicating plasmids in pseudomonas2012